tiprankstipranks
Ayalon Holdings Ltd. (IL:AYAL)
TASE:AYAL
Israel Market
Want to see IL:AYAL full AI Analyst Report?

Ayalon Hold. (AYAL) AI Stock Analysis

2 Followers

Top Page

IL:AYAL

Ayalon Hold.

(TASE:AYAL)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - Gpt-5.6Sol)
Rating:74Outperform
Price Target:
20,563.00
▲(39.79% Upside)
Action:Reiterated
Date:08/24/26
Overall score is supported by strong technical momentum and attractive valuation (low P/E and solid dividend yield). The main offset is fundamentals: while profitability and leverage trends are favorable, the TTM negative operating and free cash flow meaningfully weaken the financial performance assessment.
Positive Factors
Revenue and scale
Revenue reaching 7.1B alongside higher net income indicates meaningful business scale and a recovery in operating performance. A larger earnings base can support continued investment, strengthen the company’s market position, and provide a durable platform for growth over the next several quarters.
Negative Factors
Negative cash generation
Negative operating and free cash flow means recent reported earnings are not converting into cash, weakening earnings quality and internally funded growth. If this persists, the company may need to rely more heavily on liquidity or financing, reducing financial flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and scale
Revenue reaching 7.1B alongside higher net income indicates meaningful business scale and a recovery in operating performance. A larger earnings base can support continued investment, strengthen the company’s market position, and provide a durable platform for growth over the next several quarters.
Read all positive factors

Ayalon Hold. (AYAL) vs. iShares MSCI Israel ETF (EIS)

Ayalon Hold. Business Overview & Revenue Model

Company Description
Operating through its subsidiaries in Israel, Ayalon Insurance Company Ltd offers a comprehensive range of insurance products. Their health coverage extends to nursing care, medical expenses, surgical procedures and organ transplants, dental servi...
How the Company Makes Money
null...

Ayalon Hold. Financial Statement Overview

Summary
Income statement and balance sheet are solid (profitability rebound, healthy margins, strong ROE and improved leverage), but TTM cash flow is a major weakness with negative operating cash flow (-175M) and negative free cash flow (-251M), raising concerns about earnings quality and near-term funding needs.
Income Statement
73
Positive
Balance Sheet
70
Positive
Cash Flow
42
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue7.08B5.54B4.37B3.66B2.35B3.15B
Gross Profit6.19B5.54B3.87B3.19B1.90B2.73B
EBITDA675.65M777.74M389.55M283.39M312.60M1.62M
Net Income442.45M426.07M144.41M84.91M166.68M-114.09M
Balance Sheet
Total Assets24.25B20.07B19.07B15.94B15.58B16.02B
Cash, Cash Equivalents and Short-Term Investments1.03B2.71B3.60B410.07M3.23B3.08B
Total Debt1.03B690.27M734.34M697.08M732.66M793.57M
Total Liabilities22.46B18.55B18.09B15.24B14.94B15.34B
Stockholders Equity1.79B1.52B971.34M703.49M638.27M679.24M
Cash Flow
Free Cash Flow-251.01M187.87M81.33M-70.05M227.81M-389.21M
Operating Cash Flow-174.68M309.67M208.64M-65.06M335.35M-306.02M
Investing Cash Flow-103.25M-117.58M-122.87M-104.22M-5.44M-82.55M
Financing Cash Flow391.05M-54.50M-49.60M-8.96M-66.42M143.92M

Ayalon Hold. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price14710.00
Price Trends
50DMA
14412.96
Positive
100DMA
15140.21
Positive
200DMA
13046.28
Positive
Market Momentum
MACD
969.76
Negative
RSI
76.50
Negative
STOCH
92.31
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AYAL, the sentiment is Positive. The current price of 14710 is below the 20-day moving average (MA) of 15862.27, above the 50-day MA of 14412.96, and above the 200-day MA of 13046.28, indicating a bullish trend. The MACD of 969.76 indicates Negative momentum. The RSI at 76.50 is Negative, neither overbought nor oversold. The STOCH value of 92.31 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:AYAL.

Ayalon Hold. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
₪4.05B10.986.91%3.98%15.01%
75
Outperform
₪48.03B14.502.90%10.88%24.40%
75
Outperform
₪33.87B13.522.95%18.14%49.80%
74
Outperform
₪5.21B10.992.56%
69
Neutral
₪40.63B13.3523.23%3.52%28.54%147.51%
64
Neutral
₪22.52B9.321.79%-30.50%67.45%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:AYAL
Ayalon Hold.
18,360.00
11,605.23
171.81%
IL:CLIS
Clal Insurance
27,690.00
10,218.03
58.48%
IL:HARL
Harel
19,770.00
8,906.06
81.98%
IL:PHOE
Phoenix
19,050.00
7,604.45
66.44%
IL:MMHD
Menora Miv Hld
54,200.00
22,353.74
70.19%
IL:IDIN
Idi Insur
27,400.00
5,776.91
26.72%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 24, 2026